Federal Register #337TA1498

ITC Investigation: Alleged Patent Infringement of OTC Lidocaine Patches

The U.S. International Trade Commission (ITC) has initiated an investigation regarding over-the-counter topical lidocaine patches: - Government Buyer: - U.S. International Trade Commission (ITC) - OEMs and Vendors Involved: - J.A.R. Laboratories LLC (complainant) - Veridian Healthcare LLC - Perrigo Company plc - Opella Healthcare Group SAS - Chattem, Inc. - Hisamitsu Pharmaceutical Co., Inc. - Reckitt Benckiser Group PL - Products/Services Requested: - Over-the-counter topical lidocaine patches (no specific part numbers or quantities provided) - Unique or Notable Requirements: - Investigation centers on alleged infringement of U.S. Patent No. 12,109,181 - Focus on importation, sale for importation, and sale within the U.S. - Determination of existence of a domestic industry - Complainant seeks limited exclusion order and cease and desist orders against respondents

Description

The U.S. International Trade Commission has instituted an investigation based on a complaint filed by J.A.R. Laboratories LLC alleging violations related to the importation and sale of certain over-the-counter topical lidocaine patches that infringe on U.S. Patent No. 12,109,181. The investigation will determine if there is a violation of section 337 of the Tariff Act of 1930 and whether a domestic industry exists. The complainant seeks a limited exclusion order and cease and desist orders against the respondents.

View original listing